191 related articles for article (PubMed ID: 37848492)
1. Combined metabolomic and lipidomic analysis uncovers metabolic profile and biomarkers for papillary thyroid carcinoma.
Wang Z; Yang Y; Xing Y; Si D; Wang S; Lin J; Li C; Zhang J; Yin D
Sci Rep; 2023 Oct; 13(1):17666. PubMed ID: 37848492
[TBL] [Abstract][Full Text] [Related]
2. Metabolomics of papillary thyroid carcinoma tissues: potential biomarkers for diagnosis and promising targets for therapy.
Shang X; Zhong X; Tian X
Tumour Biol; 2016 Aug; 37(8):11163-75. PubMed ID: 26935059
[TBL] [Abstract][Full Text] [Related]
3. Metabolic changes associated with papillary thyroid carcinoma: A nuclear magnetic resonance-based metabolomics study.
Li Y; Chen M; Liu C; Xia Y; Xu B; Hu Y; Chen T; Shen M; Tang W
Int J Mol Med; 2018 May; 41(5):3006-3014. PubMed ID: 29484373
[TBL] [Abstract][Full Text] [Related]
4. Plasma metabolites analysis of patients with papillary thyroid cancer: A preliminary untargeted
Razavi SA; Mahmanzar M; Nobakht M Gh BF; Zamani Z; Nasiri S; Hedayati M
J Pharm Biomed Anal; 2024 Apr; 241():115946. PubMed ID: 38241910
[TBL] [Abstract][Full Text] [Related]
5. Metabolic Profiles and Blood Biomarkers to Discriminate between Benign Thyroid Nodules and Papillary Carcinoma, Based on UHPLC-QTOF-ESI
Berinde GM; Socaciu AI; Socaciu MA; Petre GE; Socaciu C; Piciu D
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542465
[TBL] [Abstract][Full Text] [Related]
6. Serum-plasma matched metabolomics for comprehensive characterization of benign thyroid nodule and papillary thyroid carcinoma.
Huang FQ; Li J; Jiang L; Wang FX; Alolga RN; Wang MJ; Min WJ; Ma G; Zhao YJ; Wang SL; Yu Y; Chen X; Zhu D; Zhu J; Wang G; Xia T; Sang JF; Lai MD; Li P; Zhu W; Qi LW
Int J Cancer; 2019 Feb; 144(4):868-876. PubMed ID: 30318614
[TBL] [Abstract][Full Text] [Related]
7. Distinct Metabolomic Profiles of Papillary Thyroid Carcinoma and Benign Thyroid Adenoma.
Xu Y; Zheng X; Qiu Y; Jia W; Wang J; Yin S
J Proteome Res; 2015 Aug; 14(8):3315-21. PubMed ID: 26130307
[TBL] [Abstract][Full Text] [Related]
8. Metabolite analysis-aided diagnosis of papillary thyroid cancer.
Chen J; Hu Q; Hou H; Wang S; Zhang Y; Luo Y; Chen H; Deng H; Zhu H; Zhang L; Liu H; Wang A; Liu Y
Endocr Relat Cancer; 2019 Dec; 26(12):829-841. PubMed ID: 31671400
[TBL] [Abstract][Full Text] [Related]
9. Integrative metabolomic characterization identifies plasma metabolomic signature in the diagnosis of papillary thyroid cancer.
Yu S; Liu C; Hou Y; Li J; Guo Z; Chen X; Zhang L; Peng S; Hong S; Xu L; Li X; Liu R; Chen S; Li B; Weng Z; Li Y; Lv W; Yu J; Xiao H
Oncogene; 2022 Apr; 41(17):2422-2430. PubMed ID: 35279704
[TBL] [Abstract][Full Text] [Related]
10. Identifying potential metabolic tissue biomarkers for papillary thyroid cancer in different iodine nutrient regions.
Sun Q; Zhao H; Liu Z; Wang F; He Q; Xiu C; Guo L; Tian Q; Fan L; Sun J; Sun D
Endocrine; 2021 Dec; 74(3):582-591. PubMed ID: 34075541
[TBL] [Abstract][Full Text] [Related]
11. [Preliminary findings for metabolite profiles of papillary thyroid carcinoma and laryngeal squamous cell carcinoma].
Fei MJ; Xu YN; Wang JD
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Oct; 31(20):1561-1565. PubMed ID: 29797950
[No Abstract] [Full Text] [Related]
12. GC-MS-based metabolomic analysis of human papillary thyroid carcinoma tissue.
Chen M; Shen M; Li Y; Liu C; Zhou K; Hu W; Xu B; Xia Y; Tang W
Int J Mol Med; 2015 Dec; 36(6):1607-14. PubMed ID: 26459747
[TBL] [Abstract][Full Text] [Related]
13. [The characteristic of metabolics of female papillary thyroid carcinoma and its relationship with primary tumor size and cervical lymph node metastases].
Zheng WJ; Xu YN; Zhou QY; Chen J; Fei MJ; Wang JD
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Feb; 51(2):105-11. PubMed ID: 26898866
[TBL] [Abstract][Full Text] [Related]
14. Non-invasive diagnosis of papillary thyroid microcarcinoma: a NMR-based metabolomics approach.
Lu J; Hu S; Miccoli P; Zeng Q; Liu S; Ran L; Hu C
Oncotarget; 2016 Dec; 7(49):81768-81777. PubMed ID: 27835583
[TBL] [Abstract][Full Text] [Related]
15. Clinical value of Cyclin D1 and P21 in the differential diagnosis of papillary thyroid carcinoma.
Wang CC; Lu DD; Shen MH; Chen RL; Zhang ZH; Lv JH
Diagn Pathol; 2023 Nov; 18(1):123. PubMed ID: 37951919
[TBL] [Abstract][Full Text] [Related]
16. A distinct serum metabolic signature of distant metastatic papillary thyroid carcinoma.
Shen CT; Zhang Y; Liu YM; Yin S; Zhang XY; Wei WJ; Sun ZK; Song HJ; Qiu ZL; Wang CR; Luo QY
Clin Endocrinol (Oxf); 2017 Dec; 87(6):844-852. PubMed ID: 28755525
[TBL] [Abstract][Full Text] [Related]
17. Integrated analysis of tumor microenvironment features to establish a diagnostic model for papillary thyroid cancer using bulk and single-cell RNA sequencing technology.
Wang Y; Song W; Li Y; Liu Z; Zhao K; Jia L; Wang X; Jiang R; Tian Y; He X
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16837-16850. PubMed ID: 37733241
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of papillary thyroid carcinoma by
Wang T; Sun Z; Wang Y; Li F; Zhou X; Tian X; Wang S
Drug Discov Ther; 2020 Sep; 14(4):187-196. PubMed ID: 32848112
[TBL] [Abstract][Full Text] [Related]
19. Deciphering novel biomarkers of lymph node metastasis of thyroid papillary microcarcinoma using proteomic analysis of ultrasound-guided fine-needle aspiration biopsy samples.
Lin P; Yao Z; Sun Y; Li W; Liu Y; Liang K; Liu Y; Qin J; Hou X; Chen L
J Proteomics; 2019 Jul; 204():103414. PubMed ID: 31195151
[TBL] [Abstract][Full Text] [Related]
20. Metabolomic Alterations in Thyrospheres and Adherent Parental Cells in Papillary Thyroid Carcinoma Cell Lines: A Pilot Study.
Caria P; Tronci L; Dettori T; Murgia F; Santoru ML; Griffin JL; Vanni R; Atzori L
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30262749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
